PubMed Central (PMC) Search Page
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2009 | 59 |
| 2010 | 60 |
| 2011 | 83 |
| 2012 | 121 |
| 2013 | 150 |
| 2014 | 127 |
| 2015 | 119 |
| 2016 | 114 |
| 2017 | 135 |
| 2018 | 120 |
| 2019 | 122 |
| 2020 | 161 |
| 2021 | 170 |
| 2022 | 131 |
| 2023 | 148 |
| 2024 | 171 |
| 2025 | 179 |
| 2026 | 157 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"EMBO Mol Med"[Journal]
2,327
results
Embargoed Articles:
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
FAP adipogenesis drives early spinal muscle loss in dysferlinopathy and reveals a therapeutic target.
- Moon YJ, McCormack N, Diehn T, Lin S, Staedler K, Bhattacharya S, Bittel DC, Wang PC, Hogarth M, Oh JS, Goh TS, Min JH, Stojkovic T, Ackermann-Bonan I, Jaiswal JK.
- EMBO Mol Med. 2026 Oct 12;18(10):4034-4058. doi: 10.1038/s44321-026-00514-5.
- PMCID: PMC13658238
Moon YJ, et al.EMBO Mol Med. 2026.PMCID: PMC13658238 -
Extracellular RNA clearance by non-canonical cell-surface MDA5 protects against lung fibrosis.
- Ishii T, Horie M, Urushiyama H, Murakami Y, Narita T, Fukui R, Miyake K, Saito A, Yamashita N, Kumano K, Kage H.
- EMBO Mol Med. 2026 Oct 12;18(10):4001-4033. doi: 10.1038/s44321-026-00513-6.
- PMCID: PMC13658825
Ishii T, et al.EMBO Mol Med. 2026.PMCID: PMC13658825 -
Microbiome-host communication via vaccenic acid modulates LRH-1/NR5A2 activity and ameliorates metabolic liver disease.
- Plazzo AP, Filz V, Prothiwa M, Lambrecht R, Delgado ME, Fleming JR, Duschek J, Pilgram E, Friedrich J, Eisenring R, Kurtz L, Stemmer K, Stenman LK, Amaya Garcia F, Unterlass M, Mayans O, Böttcher T, Brunner T.
- EMBO Mol Med. 2026 Sep 17;18(10):4059-4089. doi: 10.1038/s44321-026-00516-3.
- PMCID: PMC13658251
Plazzo AP, et al.EMBO Mol Med. 2026.PMCID: PMC13658251 -
Lysine pyruvylation: decoding the molecular language of pyruvate signaling.
- Zhang J.
- EMBO Mol Med. 2026 Sep 16;18(10):3879-3882. doi: 10.1038/s44321-026-00522-5.
- PMCID: PMC13658220
Zhang J.EMBO Mol Med. 2026.PMCID: PMC13658220 -
Targeted AAV gene therapy for neuroblastoma via direct capsid-antibody coupling.
- Luoni M, Parracino S, Giannelli SG, Morosi F, Ventura E, Di Pizio A, Muggeo S, Iannielli A, Sicardi S, Canu T, Russo T, Esposito A, Del Carro U, Pastorino F, Broccoli V.
- EMBO Mol Med. 2026 Sep 12;18(10):4117-4152. doi: 10.1038/s44321-026-00520-7.
- PMCID: PMC13658805
Luoni M, et al.EMBO Mol Med. 2026.PMCID: PMC13658805 -
Publisher Correction: IRF7 links HK1-dependent histone lactylation to fibroblast activation and cardiac fibrosis.
- Kong M, Zhu C, Xue Y, Hong W, Zhang G, Jiang D, Xu Y, Guo J.
- EMBO Mol Med. 2026 Oct;18(10):4178. doi: 10.1038/s44321-026-00505-6.
- PMCID: PMC13658792
Kong M, et al.EMBO Mol Med. 2026.PMCID: PMC13658792 -
Comprehensive functional testing in fibroblasts has strong utility to diagnose mitochondrial disease.
- Van Hove JLK, Friederich MW, Van Hove RA, Lee JC, Knight KM, Donovan TE, Silveira L, Ganetzky RD, Hirano M, Abdenur J, Butler MG, Cassiman D, Cohen BH, Elsea SH, Enns GM, Gahl WA, Gavrilova R, Geddes GC, Glamuzina EE, Goldstein A, Haas RH, Khan A, Kripps KA, Larson AA, Lehman AN, Lichter-Konecki U, Mayr JA, Morava E, Peterson JT, Rosenfeld JA, Saneto RP, Scaglia F, Shelkowitz E, Simon M, Smet JEG, Smith WE, Soler-Alfonso C, Tarnopolsky M, Van Coster RNA, Vanlander AV, Vermeersch P, Vockley J, Wigby K, Wolfe LA, Wortmann SB, Yang JH.
- EMBO Mol Med. 2026 Sep 8;18(10):4153-4172. doi: 10.1038/s44321-026-00497-3.
- PMCID: PMC13658156
Van Hove JLK, et al.EMBO Mol Med. 2026.PMCID: PMC13658156 -
FFAR2 activation induces IL-22-dependent intestinal immune responses to suppress CNS autoimmunity.
- Jevtić B, Lazarević M, Stegnjaić G, Stanisavljević S, Pilipović I, Nikolovski N, Milosavljević Z, Momčilović M, Koprivica I, Jonić N, Mićanović D, Radulović N, Marković M, Mirković K, Mišić D, Gašić U, Nikolić F, Veselinović N, Körner H, Grimm L, Lodygin D, Flügel A, Fraser G, Saksida T, Dimitrijević M, Stojanović I, Miljković Đ.
- EMBO Mol Med. 2026 Sep 3;18(10):4090-4116. doi: 10.1038/s44321-026-00517-2.
- PMCID: PMC13658244
Jevtić B, et al.EMBO Mol Med. 2026.PMCID: PMC13658244 -
New thinking for the next generation of antimalarials.
- Asiki H, Hlozek J, Wicht KJ, Woodland JG, Chibale K.
- EMBO Mol Med. 2026 Sep 2;18(10):3883-3897. doi: 10.1038/s44321-026-00515-4.
- PMCID: PMC13658803
Asiki H, et al.EMBO Mol Med. 2026.PMCID: PMC13658803 -
A cavity-reduced prefusion RSV F bivalent vaccine elicits durable and protective immunity.
- Liu L, Yan M, Liang R, Wu Q, Qu C, Wu H, Liao Z, Chen H, Zou J, Sun Z, Niu D, Wu L, Zhao L, Dai J, Shen J, Zhang L, Zhang W, Peng W.
- EMBO Mol Med. 2026 Aug 29;18(10):3979-4000. doi: 10.1038/s44321-026-00511-8.
- PMCID: PMC13658822
Liu L, et al.EMBO Mol Med. 2026.PMCID: PMC13658822